CN102174106A - 抗Met人源Fab及其阿霉素偶联物和其制法及应用 - Google Patents
抗Met人源Fab及其阿霉素偶联物和其制法及应用 Download PDFInfo
- Publication number
- CN102174106A CN102174106A CN2011100652092A CN201110065209A CN102174106A CN 102174106 A CN102174106 A CN 102174106A CN 2011100652092 A CN2011100652092 A CN 2011100652092A CN 201110065209 A CN201110065209 A CN 201110065209A CN 102174106 A CN102174106 A CN 102174106A
- Authority
- CN
- China
- Prior art keywords
- met
- fab
- humanized fab
- zorubicin
- dox
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *Oc(cccc1C(c(c2c(c(*C3)c4C[C@]3(C(CO)=O)O)O)c4O)=O)c1C2=O Chemical compound *Oc(cccc1C(c(c2c(c(*C3)c4C[C@]3(C(CO)=O)O)O)c4O)=O)c1C2=O 0.000 description 3
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100652092A CN102174106B (zh) | 2011-03-17 | 2011-03-17 | 抗Met人源Fab及其阿霉素偶联物和其制法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100652092A CN102174106B (zh) | 2011-03-17 | 2011-03-17 | 抗Met人源Fab及其阿霉素偶联物和其制法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102174106A true CN102174106A (zh) | 2011-09-07 |
CN102174106B CN102174106B (zh) | 2013-04-10 |
Family
ID=44517388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100652092A Expired - Fee Related CN102174106B (zh) | 2011-03-17 | 2011-03-17 | 抗Met人源Fab及其阿霉素偶联物和其制法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102174106B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2764024A4 (en) * | 2011-10-05 | 2015-08-19 | Samsung Electronics Co Ltd | ANTI-C-MET ANTIBODIES AND USE OF SAID ANTIBODIES |
CN111704674A (zh) * | 2020-07-07 | 2020-09-25 | 南京医科大学 | 一种靶向c-Met且自分泌PD-L1 scFv的嵌合抗原受体及其应用 |
CN111763262A (zh) * | 2020-07-07 | 2020-10-13 | 南京医科大学第二附属医院 | 一种靶向c-Met和PD-L1双特异性嵌合抗原受体及其应用 |
CN111886252A (zh) * | 2018-01-03 | 2020-11-03 | 阿戈马布治疗有限公司 | 促进胰岛细胞生长的方法 |
CN112111463A (zh) * | 2020-10-27 | 2020-12-22 | 南方医科大学 | 杂交瘤细胞株dox-6a10、单克隆抗体及其制备与用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101415730A (zh) * | 2006-03-30 | 2009-04-22 | 诺瓦提斯公司 | c-Met抗体的组合物和使用方法 |
-
2011
- 2011-03-17 CN CN2011100652092A patent/CN102174106B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101415730A (zh) * | 2006-03-30 | 2009-04-22 | 诺瓦提斯公司 | c-Met抗体的组合物和使用方法 |
Non-Patent Citations (3)
Title |
---|
SHINOMIYA N ET AL.: "Suppression of Met expression: a possible cancer treatment", 《CLIN. CANCER RES.》, 31 December 2003 (2003-12-31), pages 5085 - 5090 * |
万佳艺等: "人源天然Fab噬菌体抗体库的构建及抗c-Met抗体的筛选、鉴定", 《南京医科大学学报(自然科学版)》, 30 June 2008 (2008-06-30), pages 697 - 701 * |
朱进等: "可内化的人源抗Met 基因工程抗体Fab 的亲和力成熟与特性分析", 《生物化学与生物物理进展》, 31 December 2007 (2007-12-31), pages 73 - 79 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2764024A4 (en) * | 2011-10-05 | 2015-08-19 | Samsung Electronics Co Ltd | ANTI-C-MET ANTIBODIES AND USE OF SAID ANTIBODIES |
CN111886252A (zh) * | 2018-01-03 | 2020-11-03 | 阿戈马布治疗有限公司 | 促进胰岛细胞生长的方法 |
CN111886252B (zh) * | 2018-01-03 | 2024-06-18 | 阿戈马布治疗有限公司 | 促进胰岛细胞生长的方法 |
CN111704674A (zh) * | 2020-07-07 | 2020-09-25 | 南京医科大学 | 一种靶向c-Met且自分泌PD-L1 scFv的嵌合抗原受体及其应用 |
CN111763262A (zh) * | 2020-07-07 | 2020-10-13 | 南京医科大学第二附属医院 | 一种靶向c-Met和PD-L1双特异性嵌合抗原受体及其应用 |
CN111763262B (zh) * | 2020-07-07 | 2021-10-26 | 南京医科大学第二附属医院 | 一种靶向c-Met和PD-L1双特异性嵌合抗原受体及其应用 |
CN111704674B (zh) * | 2020-07-07 | 2022-05-03 | 南京医科大学 | 一种靶向c-Met且自分泌PD-L1 scFv的嵌合抗原受体及其应用 |
CN112111463A (zh) * | 2020-10-27 | 2020-12-22 | 南方医科大学 | 杂交瘤细胞株dox-6a10、单克隆抗体及其制备与用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102174106B (zh) | 2013-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109096396A (zh) | 一种抗pd-l1人源化纳米抗体及其应用 | |
CN102174106B (zh) | 抗Met人源Fab及其阿霉素偶联物和其制法及应用 | |
CN107683289A (zh) | IL13RAα2结合剂和其在癌症治疗中的用途 | |
CN109678965A (zh) | 嵌合抗原受体及其基因和重组表达载体、cd22-cd19双靶向性的t细胞及其应用 | |
CN107556387A (zh) | 抗gpc3和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用 | |
CN109897110A (zh) | 纳米抗体及其制备方法 | |
CN114106187B (zh) | 一种靶向ogt的特异性鲨鱼单域抗体及其制备方法和应用 | |
CN104031148B (zh) | 针对人PrPc的单克隆抗体及其应用 | |
CN103451218B (zh) | 一种新型细胞因子融合蛋白ip10单链抗体的制备方法 | |
CN104804092B (zh) | 一种抗b细胞生长刺激因子的纳米抗体及其用途 | |
CN101591395A (zh) | 抗人肿瘤血管内皮标志分子8胞外区的人源性单链抗体及其应用 | |
CN103319600B (zh) | 一种人源抗TLR4抗体Fab及其制备方法与应用 | |
TW201350502A (zh) | 發炎疾病治療劑 | |
CN106810611A (zh) | 抗cMet和CD3特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环DNA及应用 | |
CN114763384B (zh) | 靶向pd-1的单域抗体及其衍生物和用途 | |
CN109608546B (zh) | 一种dna聚合酶抑制剂及其应用 | |
CN102746402A (zh) | 全人源抗人催乳素受体单链抗体及其应用 | |
CN110734494B (zh) | 抗tspan8单克隆抗体及其用途 | |
CN108285479B (zh) | 七肽及其在制备治疗和/或诊断宫颈癌的产品中的应用 | |
CN113501873A (zh) | Rbv的蛋白结合分子及其用途 | |
CN108285480B (zh) | 十二肽及其在制备治疗和/或诊断宫颈癌的产品中的应用 | |
CN101280014A (zh) | 抗CyclinD1人源单链抗体 | |
CN108129564B (zh) | 一种全人源的抗vegf单链抗体及其应用 | |
CN106432423B (zh) | 一种α-螺旋多肽及其用途 | |
CN102229671B (zh) | 抗IMMT全人源Fab抗体及其在制备抗肝癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhu Jin Inventor after: Feng Zhenqing Inventor after: Chen Ximin Inventor before: Zhu Jin Inventor before: Feng Zhenqing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHU JIN FENG ZHENQING TO: ZHU JIN FENG ZHENQING CHEN XIMIN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SONG XIAOTONG LIN HONG CHEN RENJIE TANG XIAOJUN Free format text: FORMER OWNER: FENG ZHENQING Effective date: 20131211 Owner name: FENG ZHENQING Free format text: FORMER OWNER: ZHU JIN Effective date: 20131211 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210006 NANJING, JIANGSU PROVINCE TO: 210029 NANJING, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131211 Address after: 210029 Hanzhoung Road, Jiangsu, China, No. 140, No. Patentee after: Feng Zhenqing Patentee after: Song Xiaotong Patentee after: Lin Hong Patentee after: Chen Renjie Patentee after: Tang Xiaojun Address before: 210006 No. 2 Ming the Imperial Palace Road, Jiangsu, Nanjing Patentee before: Zhu Jin Patentee before: Feng Zhenqing |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151014 Address after: 230084 Anhui city in Hefei Province, the nest through the open area Bantang Zhen Tang Road No. 96 Patentee after: ANHUI SINOBIOWAY CELL THERAPY CO.,LTD. Address before: 210029 Hanzhoung Road, Jiangsu, China, No. 140, No. Patentee before: Feng Zhenqing Patentee before: Song Xiaotong Patentee before: Lin Hong Patentee before: Chen Renjie Patentee before: Tang Xiaojun |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 |
|
CF01 | Termination of patent right due to non-payment of annual fee |